Advanced micro-nano-bio systems for future targeted therapies

Current Nanoscience

Volumn 11, Issue 2, 2015, Pages 144-160

  Ricotti, Leonardo ^a   Cafarelli, Andrea ^a   Iacovacci, Veronica ^a   Vannozzi, Lorenzo ^a   Menciassi, Arianna ^a  

^a SCUOLA SUPERIORE SANT ANNA   (Italy)

Author keywords

Drug delivery; Micro nano bio systems; Microrobotics; Nanocarriers; Nanomedicine; Nanorobotics; Nanotechnology; Targeted therapy

Indexed keywords

DRUG DELIVERY; MEDICAL NANOTECHNOLOGY; NANOROBOTICS; NANOTECHNOLOGY; ROBOTICS;

MICRO ROBOTICS; MICRO-NANO; NANO-CARRIERS; PERSONALIZED MEDICINES; RESPONSIVE MATERIALS; SYSTEM INTEGRATION; TARGETED THERAPY; THERAPY STRATEGIES;

DRUG THERAPY;

ANTINEOPLASTIC AGENT; DOXORUBICIN; NANOCAPSULE; NANOCARRIER; NANOMATERIAL; POLYMER;

ARTICLE; BIOTECHNOLOGY; DRUG DELIVERY SYSTEM; ELECTROPORATION; HUMAN; MOLECULARLY TARGETED THERAPY; NANOMEDICINE; NANOTECHNOLOGY; PERSONALIZED MEDICINE; PRIORITY JOURNAL; ROBOTICS; ULTRASOUND;

EID: 84924874168     PISSN: 15734137     EISSN: 18756786     Source Type: Journal    
DOI: 10.2174/1573413710666141114221246     Document Type: Article

References (190)

1. Green, M.R. Targeting targeted therapy. N. Engl. J. Med., 2004, 350, 2191-2193.
2. Ehrlich, P. Collected Studies on Immunity. John Wiley: New York, 1906.
3. Strebhardt, K.; Ullrich, A. Paul Ehrlich’s magic bullet concept: 100 years of progress. Nat. Rev. Cancer., 2008, 8, 473-480.
4. Feynman, R.P. There’s plenty of room at the bottom. Caltech’s Eng. Sci., 1960, 23, 22-36.
5. Drexler, K.E. Molecular engineering: an approach to the development of general capabilities for molecular manipulation. Proc. Natl. Acad. Sci., 1981, 78, 5275-5278.
6. Ferrari, M. Cancer nanotechnology: opportunities and challenges. Nat. Rev. Cancer., 2005, 5, 161-171.
7. Peer, D.; Karp, J.M.; Hong, S.; Farokhzad, O.C.; Margalit, R.; Langer, R. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol., 2007, 2, 751-760.
8. Sanna, V.; Pala, N.; Sechi, M. Targeted therapy using nanotechnology: focus on cancer. Int. J. Nanomed., 2014, 9, 467-483.
9. Maeda, H.; Wu, J.; Sawa, T.; Matsumura, Y.; Hori, K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Release, 2000, 65, 271-284.
10. Canton, I.; Battaglia, G. Endocytosis at the nanoscale. Chem. Soc. Rev., 2012, 41, 2718-2739.
11. Gupta, P.; Vermani, K.; Garg, S. Hydrogels: from controlled release to pH-responsive drug delivery. Drug Discov. Today, 2002, 7, 569-579.
12. Timko, B.P.; Dvir, T.; Kohane, D.S. Remotely triggerable drug delivery systems. Adv. Mater., 2010, 22, 4925-4943.
13. Requicha, A.A.G. Nanorobots, NEMS, and nanoassembly. Proc. IEEE, 2003, 91, 1922-1933.
14. Sitti, M. Miniature devices: voyage of the microrobots. Nature, 2009, 458, 1121-1122.
15. Lenaghan, S.C.; Wang, Y.; Xi, N.; Fukuda, T.; Tarn, T.; Hamel, W.R.; Zhang, M. Grand challenges in bioengineered nanorobotics for cancer therapy. IEEE Trans. Biomed. Eng., 2013, 60, 667-673.
16. Ferreira, A.; Martel, S. Guest editorial: special issue on nanorobotics. IEEE Trans. Rob., 2014, 30, 1-2.
17. Ehrick, J.D.; Deo, S.K.; Browning, T.W.; Bachas, L.G.; Madou, M.J.; Daunert, S. Genetically engineered protein in hydrogels tailors stimuli-responsive characteristics. Nat. Mater., 2005, 4, 298-302.
18. Ricotti, L.; Menciassi, A. Engineering stem cells for future medicine. IEEE Trans. Biomed. Eng., 2013, 60, 727-734.
19. Lai, R.C.; Yeo, R.W.Y.; Tan, K.H.; Lim, S.K. Exosomes for drug delivery -a novel application for the mesenchymal stem cell. Biotechnol. Adv., 2013, 31, 543-551.
20. Martel, S.; Mohammadi, M.; Felfoul, O.; Lu, Z.; Pouponneau, P. Flagellated magnetotactic bacteria as controlled MRI-trackable propulsion and steering systems for medical nanorobots operating in the human microvasculature. Int. J. Rob. Res., 2009, 28, 571-582.
21. Danhier, F.; Feron, O.; Préat, V. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J. Control. Release, 2010, 148, 135-146.
22. Hillaireau, H.; Couvreur, P. Nanocarriers' entry into the cell: relevance to drug delivery. Cell. Mol. Life Sci., 2009, 66, 2873-2896.
23. Vasir, J.K.; Reddy, M.K.; Labhasetwar, V.D. Nanosystems in drug targeting: opportunities and challenges. Curr. Nanosci., 2005, 1, 47-64.
24. Storm, G.; Belliot, S.O.; Daemen, T.; Lasic, D.D. Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system. Adv. Drug Deliv. Rev., 1995, 17(1), 31-48.
25. Stevanovic, M.; Uskokovic, D. Poly (lactide-co-glycolide)-based micro and nanoparticles for the controlled drug delivery of vitamins. Curr. Nanosci., 2009, 5(1), 1-14.
26. Sutton, D.; Nasongkla, N.; Blanco, E.; Gao, J. Functionalized micellar systems for cancer targeted drug delivery. Pharm. Res., 2007, 24(6), 1029-1046.
27. Lv, Y.; Yang, B.; Li, Y.-M.; Wu, Y.; He, F.; Zhuo, R.-X. Crosslinked triblock copolymeric micelle for redox-responsive drug delivery. Coll. Surf. B: Biointerf., 2014, 122, 223-230.
28. Saadat, E.; Amini, M.; Dinarvand, R.; Dorkoosh, F.A. Polymeric micelles based on hyaluronic acid and phospholipids: Design, characterization, and cytotoxicity. J. Appl. Polym. Sci., 2014, 131(20), 40944.
29. Maherani, B.; Arab-Tehrany, E.R.; Mozafari, M.; Gaiani, C.; Linder, M. Liposomes: a review of manufacturing techniques and targeting strategies. Curr. Nanosci., 2011, 7(3), 436-452.
30. Wientjes, M.G.; Yeung, B.Z.; Lu, Z.; Wientjes, M.G.; Au, J.L. Predicting diffusive transport of cationic liposomes in 3-dimensional tumor spheroids. J. Control. Release, 2014, 192, 10-18.
31. Kannan, R.M.; Nance, E.; Kannan, S.; Tomalia, D.A. Emerging concepts in dendrimer‐based nanomedicine: from design principles to clinical applications. J. Int. Med., 2014, doi: 10.1111/joim.12280.
32. Mignani, S.; El Kazzouli, S.; Bousmina, M.; Majoral, J.P. Expand classical drug administration ways by emerging routes using dendrimer drug delivery systems: a concise overview. Adv. Drug Deliv. Rev., 2013, 65, 1316-1330.
33. Shen, M.; Sun, K.; Shi, X. Hydroxylated dendrimer-stabilized gold and silver nanoparticles: Spontaneous formation, characterization, and surface properties. Curr. Nanosci., 2010, 6(3), 307-314.
34. Duncan, R. Polymer conjugates as anticancer nanomedicines. Nat. Rev. Cancer, 2006, 6, 688-701.
35. Seymour, L.W. Ferry, D.R. Anderson, D. Hesslewood, S. Julyan, P.J. Poyner, R. Doran, J. Young, A.M. Burtles, S. Kerr,; Cancer Research Campaign Phase I/II Clinical Trials committee. Hepatic drug targeting: phase I evaluation of polymer-bound doxorubicin. J. Clin. Oncol., 2002, 20(6), 1668-1676.
36. Liu, Y.; Sun, J.; Han, J.; He, Z. Long-circulating targeted nanoparticles for cancer therapy. Curr. Nanosci., 2010, 6(4), 347-354.
37. Ezzati, N.D.J.; Omidi, Y.; Losic, D. Carbon nanotubes as an advanced drug and gene delivery nanosystem. Curr. Nanosci., 2011, 7(3), 297-314.
38. Talevi, A.E.; Gantner, M.E.; Ruiz, M. Applications of nanosystems to anticancer drug therapy (part I. nanogels, nanospheres, nanocapsules) Rec. Pat. Anti-Cancer Drug Discov., 2014, 9(1), 83-98.
39. Carmeliet, P.; Jain, R.K. Angiogenesis in cancer and other diseases. Nature, 2000, 407(6801), 249-257.
40. Jain, R.K.; Stylianopoulos, T. Delivering nanomedicine to solid tumors. Adv. Drug Deliv. Rev., 2010, 7(11), 653-664.
41. Gref, R.; Minamitake, Y.; Peracchia, M.T.; Trubetskoy, V.; Torchilin, V.; Langer, R. Biodegradable long-circulating polymeric nanospheres. Science, 1994, 263(5153), 1600-1603.
42. Shi, J.; Xiao, Z.; Kamaly, N.; Farokhzad, O.C. Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation. Acc. Chem. Res., 2011, 44(10), 1123-1134.
43. Kamaly, N.; Xiao, Z.; Valencia, P.M.; Radovic-Moreno, A.F.; Farokhzad, O.C. Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem. Soc. Rev., 2012, 41(7), 2971-3010.
44. Lammers, T.; Kiessingl, F.; Hennink, W.E.; Storm, G. Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress. J. Control. Release, 2012, 161(2), 175-187.
45. Arap, W.; Pasqualini, R.; Ruoslahti, E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science, 1998, 279(5349), 377-380.
46. Mitra, A.; Mulholland, J.; Nan, A.; McNeill, E.; Ghandehari, H.; Line, B.R. Targeting tumor angiogenic vasculature using polymer-RGD conjugates. J. Control. Release, 2005, 102(1), 191-201.
47. Arruebo, M.; Fernádez-Pacheco, R.; Ibarra, M.R.; Santamaría, J. Magnetic nanoparticles for drug delivery. Nano Today, 2007, 2(3), 22-32.
48. Zhang, P.; Huang, W.; Xu, H.; Chang, S.; Cao, C.; Kong, M.; He, Y. Magnetic cylindrical ordered mesoporous nanocarriers for targeted drug delivery. Micropor. Mesopor. Mater., 2014, 188, 86-92.
49. Singh, R.K.; Patel, K.D.; Kim, J.J.; Kim, T.H.; Kim, J.H.; Shin, U.S.; Lee, E.J.; Knowles, J.C.; Kim, H.W. Multifunctional hybrid nanocarrier: Magnetic CNTs ensheathed with mesoporous silica for drug delivery and imaging system. ACS Appl. Mater. Interf., 2014, 6(4), 2201-2208.
50. Xie, H.; Poyraz, S.; Thu, M.; Liu, Y.; Snyder, E.Y.; Smith, J.W.; Zhang, X. Microwave-assisted fabrication of carbon nanotubes decorated polymeric nano-medical platforms for simultaneous drug delivery and magnetic resonance imaging. RSC Adv., 2014, 4(11), 5649-5652.
51. Li, Z.; Dong, K.; Huang, S.; Ju, E.; Liu, Z.; Yin, M.; Ren, J, Qu, X. A smart nanoassembly for multistage targeted drug delivery and magnetic resonance imaging. Adv. Funct. Mater., 2014, 24(23), 3612-3620.
52. Zhou, Z.; Sun Y.; Shen, J.; Wei, J., Yu, C.; Kong, B.; Liu, W.; Yang, H.; Yang, S.; Wang, W. Iron/iron oxide core/shell nanoparticles for magnetic targeting MRI and near-infrared photothermal therapy. Biomaterials, 2014, 35(26), 7470-7478.
53. Di Corato, R.; Espinosa, A.; Lartigue, L.; Tharaud M.; Chat, S.; Pellegrino, T.; Ménager, C.; Gazeau, F.; Wilhelm, C. Magnetic hyperthermia efficiency in the cellular environment for different nanoparticle designs. Biomaterials, 2014, 35(24), 6400-6411.
54. Sadhukha, T.; Wiedmann, T.S.; Panyam, J. Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy. Biomaterials, 2013, 34(21), 5163-5171.
55. Hosseinkhani, H.; Chen, Y.-R.; He, W.; Hong, P.-D.; Yu, D.-S.; Domb, A.J. Engineering of magnetic DNA nanoparticles for tumor-targeted therapy. J. Nanopart. Res., 2013, 15(1), 1-10.
56. Lee, J.-H.; Jang, J.-T.; Choi, J.-S.; Moon, S.H.; Noh, S.-H.; Kim, J.-W.; Kim, J.-G.; Kim, I.-S.; Park, K.I.; Cheon, J. Exchange-coupled magnetic nanoparticles for efficient heat induction. Nat. Nanotechnol., 2011, 6(7), 418-422.
57. Lartigue, L.; Innocenti, C.; Kalaivani, T.; Awwad, A.; Duque, M.S.; Guari, Y.; Larionova, J.; Guérin, C.; Montero, J.L.G.; Barragan-Montero, V.; Arosio, P.; Lascialfari, A.; Gatteschi, D, Sangregorio, C. Water-dispersible sugar-coated iron oxide nanoparticles. An evaluation of their relaxometric and magnetic hyperthermia properties. J. Am. Chem. Soc., 2011, 133(27), 10459-10472.
58. Asín, L.; Ibarra, M.R.; Tres, A.; Goya, G.F. Controlled cell death by magnetic hyperthermia: effects of exposure time, field amplitude, and nanoparticle concentration. Pharm. Res., 2012, 29(5), 1319-1327.
59. Neuberger, T.; Schöpf, B.; Hofmann, H.; Hofmann, M.; von Rechenberg, B. Superparamagnetic nanoparticles for biomedical applications: possibilities and limitations of a new drug delivery system. J. Magn. Magn. Mater., 2005, 293(1), 483-496.
60. Pisanic, T.R.II; Blackwell, J.D.; Shubayev, V.I.; Fiñones, R.R.; Jin, S. Nanotoxicity of iron oxide nanoparticle internalization in growing neurons. Biomaterials, 2007, 28(16), 2572-2581.
61. Jain, T.K.; Reddy, M.K.; Morales, M.A.; Leslie-Pelecky, D.L.; Labhasetwar, V. Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats. Mol. Pharm., 2008, 5(2), 316-327.
62. Zhao, Y.-Z.; Du, L.-N.; Lu, C.-T.; Jin, Y.-G.; Ge, S.-P. Potential and problems in ultrasound-responsive drug delivery systems. Int. J. Nanomed., 2013, 8, 1621-1633.
63. Pua, E.C.; Zhong, P. Ultrasound-mediated drug delivery. IEEE Eng. Med. Biol. Mag., 2009, 28(1), 64-75.
64. Yu, H.; Xu, L. Cell experimental studies on sonoporation: State of the art and remaining problems. J. Control. Release, 2014, 174, 151-160.
65. Qiu, Y.; Zhang, C.; Tu, J.; Zhang, D. Microbubble-induced sonoporation involved in ultrasound-mediated DNA transfection in vitro at low acoustic pressures. J. Biomech., 2012, 45(8), 1339-1345.
66. Escoffre, J.; Novell, A.; Piron, J.; Zeghimi, A.; Doinikov, A.; Bouakaz, A. Microbubble attenuation and destruction: are they involved in sonoporation efficiency? IEEE Trans. Ultrason. Ferroelectr. Freq. Contr., 2013, 60(1), 46-52.
67. Fan, Z.; Kumon, R.E.; Deng, C.X. Mechanisms of microbubble-facilitated sonoporation for drug and gene delivery. Therap. Deliv., 2014, 5(4), 467-486.
68. Sirsi, S.R.; Borden, M.A., State-of-the-art materials for ultrasound-triggered drug delivery. Adv. Drug Deliv. Rev., 2013, 72, 3-14.
69. Lammers, T.; Aime, S.; Hennink, W.E.; Storm, G.; Kiessling, F. Theranostic nanomedicine. Accounts Chem. Res., 2011, 44(10), 1029-1038.
70. Mo, S.; Coussios, C.-C.; Seymour, L.; Carlisle, R. Ultrasound-enhanced drug delivery for cancer. Exp. Opin. Drug Deliv., 2012, 9 (12), 1525-1538.
71. Hill, C.R.; Bamber, J.C.; ter Haar, G.R. Physical Principles of Medical Ultrasonics. 2nd ed.; John Wiley & Sons Ltd: Chicester, 2004; p 530.
72. Nelson, T.R.; Fowlkes, J.B.; Abramowicz, J.S.; Church, C.C. Ultrasound biosafety considerations for the practicing sonographer and sonologist. J. Ultrasound. Med., 2009, 28(2), 139.
73. Hernot, S.; Klibanov, A.L. Microbubbles in ultrasound-triggered drug and gene delivery. Adv. Drug Deliv. Rev., 2008, 60(10), 1153-1166.
74. Stride, E.; Coussios, C. Cavitation and contrast: the use of bubbles in ultrasound imaging and therapy. Proc. Inst. Mech. Eng. H: J. Eng. Med., 2010, 224(2), 171-191.
75. Kiessling, F.; Fokong, S.; Koczera, P.; Lederle, W.; Lammers, T. Ultrasound microbubbles for molecular diagnosis, therapy, and theranostics. J. Nucl. Med., 2012, 53(3), 345-348.
76. Chen, H.; Hwang, J.H. Ultrasound-targeted microbubble destruction for chemotherapeutic drug delivery to solid tumors. J. Ther. Ultrasound., 2013, 1(1), 10.
77. Petit, B.; Tranquart, F.Y.F.; Allemann, E. Microbubbles and ultrasound-mediated thrombolysis: a review of recent in vitro studies. J. Drug Deliv. Sci. Technol., 2012, 22(5), 377-452.
78. Liao, Y.-Y.; Chen, Z.-Y.; Wang, Y.-X.; Lin, Y.; Yang, F.; Zhou, Q.-L. New progress in angiogenesis therapy of cardiovascular disease by ultrasound targeted microbubble destruction. BioMed Res. Int., 2014, 2014, 872984.
79. Yan, P.; Chen, K.-J.; Wu, J.; Sun, L.; Sung, H.-W.; Weisel, R.D.; Xie, J.; Li, R.-K. The use of MMP2 antibody-conjugated cationic microbubble to target the ischemic myocardium, enhance Timp3 gene transfection and improve cardiac function. Biomaterials, 2014, 35(3), 1063-1073.
80. Chen, Z.-Y.; Lin, Y.; Yang, F.; Jiang, L.; Ge, S.P. Gene therapy for cardiovascular disease mediated by ultrasound and microbubbles. Cardiovasc. Ultrasound., 2013, 11, 11.
81. Bioley, G.; Lassus, A.; Bussat, P.; Terrettaz, J.; Tranquart, F.; Corthésy, B. Gas-filled microbubble-mediated delivery of antigen and the induction of immune responses. Biomaterials, 2012, 33(25), 5935-5946.
82. Azagury, A.; Khoury, L.; Enden, G.; Kost, J. Ultrasound mediated transdermal drug delivery. Adv. Drug Deliv. Rev., 2014, 72, 127-143.
83. Etame, A.B.; Diaz, R.J.; Smith, C.A.; Mainprize, T.G.; Hynynen, K.; Rutka, J.T. Focused ultrasound disruption of the blood-brain barrier: a new frontier for therapeutic delivery in molecular neurooncology. Neurosurg. Focus., 2012, 32(1), E3.
84. Schroeder, A.; Kost, J.; Barenholz, Y. Ultrasound, liposomes, and drug delivery: principles for using ultrasound to control the release of drugs from liposomes. Chem. Phys. Lipids, 2009, 162(1), 1-16.
85. Escoffre, J.; Novell, A.; de Smet, M.; Bouakaz, A. Focused ultrasound mediated drug delivery from temperature-sensitive liposomes: in-vitro characterization and validation. Phys. Med. Biol., 2013, 58(22), 8135.
86. Grüll, H.; Langereis, S. Hyperthermia-triggered drug delivery from temperature-sensitive liposomes using MRI-guided high intensity focused ultrasound. J. Control. Release, 2012, 161(2), 317-327.
87. Afadzi, M.; Strand, S.P.; Nilssen, E.A.; Masoy, S.-E.; Johansen, T.F.; Hansen, R.; Angelsen, B.A.; de L. Davies, C. Mechanisms of the ultrasound-mediated intracellular delivery of liposomes and dextrans. IEEE Trans. Ultrason. Ferroelectr. Freq. Contr., 2013, 60(1), 21-33.
88. Dromi, S.; Frenkel, V.; Luk, A.; Traughber, B.; Angstadt, M.; Bur, M.; Poff, J.; Xie, J.; Libutti, S.K.; Li, K.C. Pulsed-high intensity focused ultrasound and low temperature-sensitive liposomes for enhanced targeted drug delivery and antitumor effect. Clin. Cancer Res., 2007, 13(9), 2722-2727.
89. Pitt, W.G.; Husseini, G.A.; Kherbeck, L.N. Ultrasound-triggered release from micelles. Smart materials for drug delivery, Royal Society of Chemistry, London 2013, pp. 148-178.
90. Kedar, U.; Phutane, P.; Shidhaye, S.; Kadam, V. Advances in polymeric micelles for drug delivery and tumor targeting. Nanomed. Nanotechnol. Biol. Med., 2010, 6(6), 714-729.
91. Husseini, G.A.; Pitt, W.G. Micelles and nanoparticles for ultrasonic drug and gene delivery. Adv. Drug Deliv. Rev., 2008, 60(10), 1137-1152.
92. Pelletier, M.; Babin, J.; Tremblay, L.; Zhao, Y. Investigation of a new thermosensitive block copolymer micelle: hydrolysis, disruption, and release. Langmuir, 2008, 24(21), 12664-12670.
93. Deng, L.; Li, L.; Yang, H.; Li, L.; Zhao, F.; Wu, C.; Liu, Y. Development and optimization of doxorubicin loaded poly (lactic-co-glycolic acid) nanobubbles for drug delivery into HeLa cells. J. Nanosci. Nanotechnol., 2014, 14(4), 2947-2954.
94. Yin, T.; Wang, P.; Li, J.; Zheng, R.; Zheng, B.; Cheng, D.; Li, R.; Lai, J.; Shuai, X. Ultrasound-sensitive siRNA-loaded nanobubbles formed by hetero-assembly of polymeric micelles and liposomes and their therapeutic effect in gliomas. Biomaterials, 2013, 34(18), 4532-4543.
95. Geers, B.; Lentacker, I.; Sanders, N.N.; Demeester, J.; Meairs, S.; De Smedt, S.C. Self-assembled liposome-loaded microbubbles: The missing link for safe and efficient ultrasound triggered drug-delivery. J. Control. Release, 2011, 152(2), 249-256.
96. Husseini, G.A.; Velluto, D.; Kherbeck, L.; Pitt, W.G.; Hubbell, J.A.; Christensen, D.A. Investigating the acoustic release of doxorubicin from targeted micelles. Coll. Surf B: Biointerf., 2013, 101, 153-155.
97. Heath, C.H.; Sorace, A.; Knowles, J.; Rosenthal, E.; Hoyt, K. Microbubble therapy enhances anti-tumor properties of cisplatin and cetuximab in vitro and in vivo. Otolaryngol. Head Neck Surg., 2012, 146, 938-945.
98. Ranjan, A.; Jacobs, G.C.; Woods, D.L.; Negussie, A.H.; Partanen, A.; Yarmolenko, P.S.; Gacchina, C.E.; Sharma, K.V.; Frenkel, V.; Wood, B.J. Image-guided drug delivery with magnetic resonance guided high intensity focused ultrasound and temperature sensitive liposomes in a rabbit Vx2 tumor model. J. Control. Release, 2012, 158(3), 487-494.
99. Ciofani, G.; Menciassi, A. Piezoelectric nanomaterials for biomedical applications. Springer-Verlag., Berlin Heidelberg, 2012.
100. Ciofani, G.; Danti, S.; D’Alessandro, D.; Ricotti, L.; Moscato, S.; Bertoni, G.; Falqui, A.; Berrettini, S.; Petrini, M.; Mattoli, V. Enhancement of neurite outgrowth in neuronal-like cells following boron nitride nanotube-mediated stimulation. ACS Nano, 2010, 4(10), 6267-6277.
101. Ricotti, L.; Fujie, T.; Vazão, H.; Ciofani, G.; Marotta, R.; Brescia, R.; Filippeschi, C.; Corradini, I.; Matteoli, M.; Mattoli, V. Boron nitride nanotube-mediated stimulation of cell co-culture on microengineered hydrogels. PloS ONE, 2013, 8(8), e71707.
102. Ricotti, L.; das Neves, R.P.; Ciofani, G.; Canale, C.; Nitti, S.; Mattoli, V.; Mazzolai, B.; Ferreira, L.; Menciassi, A. Boron nitride nanotube-mediated stimulation modulates F/G-actin ratio and mechanical properties of human dermal fibroblasts. J. Nanopart. Res., 2014, 16(2), 1-14.
103. ter Haar, G.; Shaw, A.; Pye, S.; Ward, B.; Bottomley, F.; Nolan, R.; Coady, A.-M. Guidance on reporting ultrasound exposure conditions for bio-effects studies. Ultrasound Med. Biol., 2011, 37(2), 177-183.
104. Castle, J.; Butts, M.; Healey, A.; Kent, K.; Marino, M.; Feinstein, S.B. Ultrasound-mediated targeted drug delivery: recent success and remaining challenges. Am. J. Physiol-Heart Circ. Physiol., 2013, 304(3), H350-H357.
105. Gehl, J. Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol. Scandinav., 2003, 177(4), 437-447.
106. Gehl, J. Electroporation for drug and gene delivery in the clinic: doctors go electric. In: Li, S. Ed. Electroporation Protocols -preclinical and clinical gene medicine, Humana Press, Totowa (New Jersey). 2008, pp. 351-359.
107. Bodles-Brakhop, A.M.; Heller, R.; Draghia-Akli, R. Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments. Mol. Ther., 2009, 17(4), 585-592.
108. Mir, L.M. Application of electroporation gene therapy: past, current, and future. In: Li, S. Ed. Electroporation Protocols -preclinical and clinical gene medicine, Humana Press, Totowa (New Jersey). 2008, pp. 3-17.
109. Rastogi, R.; Anand, S.; Koul, V. Electroporation of polymeric nanoparticles: an alternative technique for transdermal delivery of insulin. Drug Dev. Ind. Pharm., 2010, 36(11), 1303-1311.
110. Xie, X.; Xu, A.M.; Leal-Ortiz, S.; Cao, Y.; Garner, C.C.; Melosh, N.A. Nanostraw-electroporation system for highly efficient intracellular delivery and transfection. ACS Nano, 2013, 7(5), 4351-4358.
111. Xie, C.; Lin, Z.; Hanson, L.; Cui, Y.; Cui, B. Intracellular recording of action potentials by nanopillar electroporation. Nat. Nanotechnol., 2012, 7(3), 185-190.
112. Kang, W.; Yavari, F.; Minary-Jolandan, M.; Giraldo-Vela, J.P.; Safi, A.; McNaughton, R. L.; Parpoil, V.; Espinosa, H.D. Nanofountain probe electroporation (NFP-E) of single cells. Nano Lett., 2013, 13(6), 2448-2457.
113. Boukany, P.E.; Morss, A.; Liao, W.C.; Henslee, B.; Jung, H.; Zhang, X.; Yu, B.; Wang, X.; Wu, Y.; Li, L.; Gao, K.; Hu, X.; Zhao, X.; Hemminger, O.; Lu, W.; Lafyatis G.P.; Lee, L.J. Nanochannel electroporation delivers precise amounts of biomolecules into living cells. Nat. Nanotechnol., 2011, 6(11), 747-754.
114. Boukany, P.E.; Wu, Y.; Zhao, X.; Kwak, K.J.; Glazer, P.J.; Leong, K.; Lee, L.J. Nonendocytic delivery of lipoplex nanoparticles into living cells using nanochannel electroporation. Adv. Health Mater., 2014, 3(5), 682-689.
115. Gao, K.; Li, L.; He, L.; Hinkle, K.; Wu, Y.; Ma, J.; Chang, L.; Zhao, X.; Perez, D.G.; Eckardt, S.; McLaughlin, J.; Liu, B.; Farson, D.F.; Lee, L.J. Design of a microchannel-nanochannel-microchannel array based nanoelectroporation system for precise gene transfection. Small, 2014, 10(5), 1015-1023.
116. Chang, L.; Howdyshell, M.; Liao, W.; Chiang, C.; Gallego-Perez, D.; Yang, Z.; Byrd, J.; Wu, L.; Muthusamy, N.; Lee, L.J.; Sooryakumar, R. Magnetic tweezer based 3D micro-electroporation system for high throughput transfection in living cells. Small, 2014, doi: 10.1002/smll.201402564.
117. Nelson, B.J.; Kaliakatsos, I.K.; Abbott, J.J. Microrobots for minimally invasive medicine. Ann. Rev. Biomed. Eng., 2010, 12, 55-85.
118. Purcell, E.M. Life at low Reynolds number. Am. J. Phys., 1977, 45(1), 3-11.
119. Dong, L.; Nelson, B.J. Tutorial-Robotics in the small part II: nanorobotics. IEEE Rob. Autom. Mag., 2007, 14(3), 111-121.
120. Abbott, J.J.; Nagy, Z.; Beyeler, F.; Nelson, B.J. Robotics in the small part I: microrobotics. IEEE Rob. Autom. Mag., 2007, 14(3), 92-103.
121. Kósa, G.; Jakap, S.; Székely, G.; Hata, N. MRI driven magnetic microswimmers. Biomed. Microdev., 2012, 14(1), 165-178.
122. Kummer, M.P.; Abbott, J.J.; Kratochvil, B.E.; Borer, R.; Sengul, A.; Nelson, B.J. OctoMag: An electromagnetic system for 5-DOF wireless micromanipulation. IEEE Trans. Rob., 2010, 26(6), 1006-1017.
123. Peyer, K.E.; Tottori, S.; Qiu, F.; Zhang, L.; Nelson, B.J. Magnetic helical micromachines. Chem. Eur. J., 2013, 19(1), 28-38.
124. Khalil, I.S.M.; Dijkslag, H.C.; Abelmann, L.; Misra, S. MagnetoSperm: A microrobot that navigates using weak magnetic fields. Appl. Phys. Lett., 2014, 104(22), 223-701.
125. de Lanauze, D.; Felfoul, O.; Turcot, J.-P.; Mohammadi, M.; Martel, S. Three-dimensional remote aggregation and steering of magnetotactic bacteria microrobots for drug delivery applications. Int. J. Rob. Res., 2013, 33, 359-374.
126. Park, S.J.; Park, S.-H.; Cho, S.; Kim, D.-M.; Lee, Y.; Ko, S.Y.; Hong, Y.; Choy, H.E.; Min, J.-J.; Park, J.-O.; Park, S. New paradigm for tumor theranostic methodology using bacteria-based microrobot. Sci. Rep., 2013, 3, 3394.
127. Qiu, F.; Zhang, L.; Peyer, K.E.; Casarosa, M.; Franco-Obregón, A.; Choi, H.; Nelson, B.J. Noncytotoxic artificial bacterial flagella fabricated from biocompatible ORMOCOMP and iron coating. J. Mater. Chem. B., 2014, 2(4), 357-362.
128. Wang, W.; Castro, L.A.; Hoyos, M.; Mallouk, T.E. Autonomous motion of metallic microrods propelled by ultrasound. ACS Nano, 2012, 6(7), 6122-6132.
129. Kagan, D.; Benchimol, M.J.; Claussen, J.C.; Chuluun-Erdene, E.; Esener, S.; Wang, J. Acoustic droplet vaporization and propulsion of perfluorocarbon-loaded microbullets for targeted tissue penetration and deformation. Angew Chem., 2012, 124(30), 7637-7640.
130. Wang, J.; Gao, W. Nano/microscale motors: biomedical opportunities and challenges. ACS Nano, 2012, 6(7), 5745-5751.
131. Ahmed, S.; Wang, W.; Mair, L.O.; Fraleigh, R.D.; Li, S.; Castro, L.A.; Hoyos, M.; Huang, T.J.; Mallouk, T.E. Steering acoustically propelled nanowire motors toward cells in a biologically compatible environment using magnetic fields. Langmuir, 2013, 29(52), 16113-16118.
132. Búzás, A.; Kelemen, L.; Mathesz, A.; Oroszi, L.; Vizsnyiczai, G.; Vicsek, T.; Ormos, P. Light sailboats: Laser driven autonomous microrobots. Appl. Phys. Lett., 2012, 101(4), 041111.
133. Pelrine, R.; Wong-foy, A.; McCoy, B.; Holeman, D.; Mahoney, R.; Myers, G.; Herson, J.; Low, T. Diamagnetically levitated robots: An approach to massively parallel robotic systems with unusual motion properties. IEEE Int. Conf. Rob. Autom. (ICRA), 2012, 739-744.
134. Donald, B.R.; Levey, G.C.; McGray, C.D.; Paprotny, I.; Rus, D. An untethered, electrostatic, globally controllable MEMS micro-robot. J. Microelectromech. Syst., 2006, 15(1), 1-15.
135. Gao, W.; D’Agostino, M.; Garcia-Gradilla, V.; Orozco, J.; Wang, J. Multi-fuel driven Janus micromotors. Small, 2013, 9(3), 467-471.
136. Bao, J.; Yang, Z.; Nakajima, M.; Shen, Y.; Takeuchi, M.; Huang, Q.; Fukuda, T. Self-actuating asymmetric platinum catalytic mobile nanorobot. IEEE Trans. Rob., 2014, 30(1), 33-39.
137. Hong, W.; Zhao, G.; Pumera, M. Beyond platinum: bubble-propelled micromotors based on Ag and MnO2 catalysts. J. Am. Chem. Soc., 2014, 136(7), 2719-2722.
138. Mano, N.; Heller, A. Bioelectrochemical propulsion. J. Am. Chem. Soc., 2005, 127(33), 11574-11575.
139. Mhanna, R.; Qiu, F.; Zhang, L.; Ding, Y.; Sugihara, K.; Zenobi-Wong, M.; Nelson, B.J. Artificial bacterial flagella for remote-controlled targeted single-cell drug delivery. Small, 2014, 10(10), 1953-1957.
140. Dreyfus, R.; Baudry, J.; Roper, M.L.; Fermigier, M.; Stone, H.A.; Bibette, J. Microscopic artificial swimmers. Nature, 2005, 437, 862-865.
141. Ricotti, L.; Menciassi, A. Bio-hybrid muscle cell-based actuators. Biomed. Microdev., 2012, 14(6), 987-998.
142. Taherkhani, S.; Mohammadi, M.; Daoud, J.; Martel, S.; Tabrizian, M. Covalent binding of nanoliposomes to the surface of magnetotactic bacteria for the synthesis of self-propelled therapeutic agents. ACS Nano, 2014, 8(5), 5049-5060.
143. Li, H.; Tan, J.; Zhang, M. Dynamics modeling and analysis of a swimming microrobot for controlled drug delivery. IEEE Trans. Autom. Sci. Eng., 2009, 6(2), 220-227.
144. Cavalcanti, A.; Shirinzadeh, B.; Fukuda, T.; Ikeda, S. Nanorobot for brain aneurysm. Int. J. Rob. Res., 2009, 28(4), 558-570.
145. Hamdi, M.; Ferreira, A. Guidelines for the design of magnetic nanorobots to cross the blood-brain barrier. IEEE Trans. Rob., 2014, 30(1), 81-92.
146. Ghosh, A.; Fischer, P. Controlled propulsion of artificial magnetic nanostructured propellers. Nano Lett., 2009, 9(6), 2243-2245.
147. Fusco, S.; Sakar, M.S.; Kennedy, S.; Peters, C.; Bottani, R.; Starsich, F.; Mao, A.; Sotiriou, G.A.; Pané, S.; Pratsinis, S.E.; Mooney, D.; Nelson, B.J. Targeted delivery: an integrated microrobotic platform for on-demand, targeted therapeutic interventions. Adv. Mater., 2014, 26(6), 951-951.
148. Godin, B.; Tasciotti, E.; Liu, X.; Serda, R.E.; Ferrari, M. Multistage nanovectors: from concept to novel imaging contrast agents and therapeutics. Acc. Chem. Res., 2011, 44(10), 979-989.
149. Seeman, N.C. Nucleic acid junctions and lattices. J. Theor. Biol., 1982, 99(2), 237-247.
150. Rothemund, P.W. Folding DNA to create nanoscale shapes and patterns. Nature, 2006, 440(7082), 297-302.
151. Pinheiro, A.V.; Han, D.; Shih, W.M.; Yan, H. Challenges and opportunities for structural DNA nanotechnology. Nat. Nanotechnol., 2011, 6(12), 763-772.
152. Tørring, T.; Voigt, N.V.; Nangreave, J.; Yan, H.; Gothelf, K.V. DNA origami: a quantum leap for self-assembly of complex structures. Chem. Soc. Rev., 2011, 40(12), 5636-5646.
153. Voigt, N.V.; Tørring, T.; Rotaru, A.; Jacobsen, M.F.; Ravnsbaek, J.B.; Subramani, R.; Mamdouh, W.; Kjems, J.; Mokhir, A.; Besenbacher, F.; Gothelf, K.V. Single-molecule chemical reactions on DNA origami. Nat. Nanotechnol., 2010, 5(3), 200-203.
154. Jahn, K.; Tørring, T.; Voigt, N.V.; Sørensen, R.S.; Kodal, A.L.B.; Andersen, E.S.; Gothelf, K.V.; Kjems, J. Functional patterning of DNA origami by parallel enzymatic modification. Bioconjug. Chem., 2011, 22(4), 819-823.
155. Han, D.; Pal, S.; Liu, Y.; Yan, H. Folding and cutting DNA into reconfigurable topological nanostructures. Nat. Nanotechnol., 2010, 5(10), 712-717.
156. Dittmer, W.U.; Reuter, A.; Simmel, F.C. A DNA-based machine that can cyclically bind and release thrombin. Angew Chem. Int. Ed., 2004, 43(27), 3550-3553.
157. Walsh, A.S.; Yin, H.; Erben, C.M.; Wood, M.J.; Turberfield, A.J. DNA cage delivery to mammalian cells. ACS Nano, 2011, 5(7), 5427-5432.
158. Zadegan, R.M.; Jepsen, M.D.; Thomsen, K.E.; Okholm, A.H.; Schaffert, D.H.; Andersen, E.S.; Birkedal, V.; Kjems, J. Construction of a 4 zeptoliters switchable 3D DNA box origami. ACS Nano, 2012, 6(11), 10050-10053.
159. Zhao, Y.X.; Shaw, A.; Zeng, X.; Benson, E.; Nystrom, A.M.; Högberg, B. DNA origami delivery system for cancer therapy with tunable release properties. ACS Nano, 2012, 6(10), 8684-8691.
160. Lee, H.; Lytton-Jean, A.K.; Chen, Y.; Love, K.T.; Park, A.I.; Karagiannis, E.D.; Sehgal, A.; Querbes, W.; Zurenko, C.S.; Jayaraman, M.; Peng, C.G.; Charisse, K.; Borodovsky, A.; Manoharan, M.; Donahoe, J.S.; Truelove, J.; Nahrendorf, M.; Langer, R.; Anderson, D.G.; Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery. Nat. Nanotechnol., 2012, 7(6), 389-393.
161. Xue, H.Y.; Liu, S.; Wong, H.L. Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicine. Nanomedicine, 2014, 9(2), 295-312.
162. Vazquez, E.; Ferrer-Miralles, N.; Mangues, R.; Corchero, J.L.; Schwartz, J.; Villaverde, A. Modular protein engineering in emerging cancer therapies. Curr. Pharm. Des., 2009, 15(8), 893-916.
163. Han, Y.; Shchukin, D.; Yang, J.; Simon, C.R.; Fuchs, H.; Möhwald, H. Biocompatible protein nanocontainers for controlled drugs release. ACS Nano, 2010, 4(5), 2838-2844.
164. MaHam, A.; Tang, Z.; Wu, H.; Wang, J.; Lin, Y. Protein-based nanomedicine platforms for drug delivery. Small, 2009, 5(15), 1706-1721.
165. Molino, N.M.; Wang, S.-W. Caged protein nanoparticles for drug delivery. Curr. Opin. Biotechnol., 2014, 28, 75-82.
166. van Dommelen, S.M.; Vader, P.; Lakhal, S.; Kooijmans, S.A.A.; van Solinge, W.W.; Wood, M.J., Schiffelers, R.M. Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery. J. Control. Release, 2012, 161(2), 635-644.
167. Alvarez-Erviti, L.; Seow, Y.; Yin, H.; Betts, C.; Lakhal, S.; Wood, M.J. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol., 2011, 29(4), 341-345.
168. Zhuang, X.; Xiang, X.; Grizzle, W.; Sun, D.; Zhang, S.; Axtell, R.C.; Ju, S.; Mu, J.; Zhang, L.; Steinman, L.; Miller, D.; Zhang, H.G. Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol. Ther., 2011, 19(10), 1769-1779.
169. Munoz, J.L.; Bliss, S.A.; Greco, S.J.; Ramkissoon, S.H.; Ligon, K.L.; Rameshwar, P. Delivery of functional anti-miR-9 by mesenchymal stem cell-derived exosomes to glioblastoma multiforme cells conferred chemosensitivity. Mol. Ther. Nucleic Acids, 2013, 2(10), e126.
170. Lakhal, S.; Wood, M.J. Exosome nanotechnology: An emerging paradigm shift in drug delivery. Bioessays, 2011, 33(10), 737-741.
171. Simpson, R.J.; Kalra, H.; Mathivanan, S. ExoCarta as a resource for exosomal research. J. Extracell. Vescic., 2012, 1, 10.3402/jev.v1i0.18374.
172. Mathivanan, S.; Fahner, C.J.; Reid, G.E.; Simpson, R.J. ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic Acids Res., 2012, 40(1), D1241-D1244.
173. Yeo, R.W.Y.; Lai, R.C.; Zhang, B.; Tan, S.S.; Yin, Y.; Teh, B.J.; Lim, S.K. Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery. Adv. Drug Deliv. Rev., 2013, 65(3), 336-341.
174. Lai, R.C.; Yeo, R.W.Y.; Tan, K.H.; Lim, S.K. Exosomes for drug delivery—a novel application for the mesenchymal stem cell. Biotechnol. Adv., 2013, 31(5), 543-551.
175. Tuerk, C.; Gold, L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science, 1990, 249(4968), 505-510.
176. Ellington, A.D.; Szostak, J.W. In vitro selection of RNA molecules that bind specific ligands. Nature, 1990, 346(6287), 818-822.
177. Tang, Z.; Shangguan, D.; Wang, K.; Shi, H.; Sefah, K.; Mallikratchy, P.; Chen, H.W. Selection of aptamers for molecular recognition and characterization of cancer cells. Anal. Chem., 2007, 79(13), 4900-4907.
178. Aravind, A.; Jeyamohan, P.; Nair, R.; Veeranarayanan, S.; Nagaoka, Y.; Yoshida, Y.; Maekawa, T.; Kumar, D.S. AS1411 aptamer tagged PLGA-lecithin-PEG nanoparticles for tumor cell targeting and drug delivery. Biotechnol. Bioeng., 2012, 109(11), 2920-2931.
179. Xiao, Z.; Levy-Nissenbaum, E.; Alexis, F.; Lupták, A.; Teply, B.A.; Chan, J.M.; Shi, J., Digga, E.; Cheng, J.; Langer, R.; Farokhzad, O.C. Engineering of targeted nanoparticles for cancer therapy using internalizing aptamers isolated by cell-uptake selection. ACS Nano, 2012, 6(1), 696-704.
180. Huang, Y.F.; Shangguan, D.; Liu, H.; Phillips, J.A.; Zhang, X.; Chen, Y.; Tan, W. Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells. ChemBioChem, 2009, 10(5), 862-868.
181. Min, K.; Jo, H.; Song, K.; Cho, M.; Chun, Y.S.; Jon, S.; Kim, W.J.; Ban, C. Dual-aptamer-based delivery vehicle of doxorubicin to both PSMA (+) and PSMA (−) prostate cancers. Biomaterials, 2011, 32(8), 2124-2132.
182. Zhou, J.; Rossi, J.J. Aptamer-targeted cell-specific RNA interference. Silence, 2010, 1(1), 4.
183. Dassie, J.P.; Liu, X.Y.; Thomas, G.S.; Whitaker, R.M.; Thiel, K.W.; Stockdale, K.R.; Meyerholz, D.K.; McCaffrey, A.P.; McNamara, J.O.; 2nd, Giangrande, P.H. Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors. Nat. Biotechnol., 2009, 27(9), 839-846.
184. Kim, D.; Jeong, Y.Y.; Jon, S. A drug-loaded aptamer− gold nanoparticle bioconjugate for combined CT imaging and therapy of prostate cancer. ACS Nano, 2010, 4(7), 3689-3696.
185. Douglas, S.M.; Bachelet, I.; Church, G.M. A logic-gated nanorobot for targeted transport of molecular payloads. Science, 2012, 335(6070), 831-834.
186. You, M.; Peng, L.; Shao, N.; Zhang, L.; Qiu, L.; Cui, C.; Tan, W. DNA “Nano-Claw”: logic-based autonomous cancer targeting and therapy. J. Am. Chem. Soc., 2014, 136(4), 1256-1259.
187. Savla, R.; Taratula, O.; Garbuzenko, O.; Minko, T. Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancer. J. Control. Release, 2011, 153(1), 16-22.
188. Koren, E.; Torchilin, V.P. Cell-penetrating peptides: breaking through to the other side. Trends Mol. Med., 2012, 18(7), 385-393.
189. Hamburg, M.A.; Collins, F.S. The path to personalized medicine. New Engl. J. Med., 2010, 363(4), 301-304.
190. La Thangue, N.B.; Kerr, D.J. Predictive biomarkers: a paradigm shift towards personalized cancer medicine. Nat. Rev. Clin. Oncol., 2011, 8(10), 587-596.